Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Urol. 2007 Apr;177(4):1264-8; discussion 1268.

Interferon-alpha resistance associated genes in renal cell carcinoma identified by expression profiling.

Author information

  • 1Department of Cell Biology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

Abstract

PURPOSE:

We identified differentially expressed genes associated with response to pegylated interferon-alpha treatment in patients with renal cell carcinoma.

MATERIALS AND METHODS:

We performed expression profiling on renal cell carcinoma specimens isolated from 23 patients with metastatic disease who were subsequently treated with interferon. Significance Analysis for Microarrays software was used to identify genes that were differentially expressed between patients with partial response compared to those with disease progression.

RESULTS:

A candidate gene approach looking at VHL and known target genes did not identify any genes whose expression correlated with patient response. A global analysis of approximately 54,000 probe sets identified 4 genes that had expression correlated with response. Reverse transcriptase-polymerase chain reaction analysis of 2 of these genes confirmed that they were more highly expressed in tumors from patients who responded to interferon-alpha. Interestingly, both of these genes mapped to 4q31-32, a region that has been implicated as the site of a potential tumor suppressor gene in renal cell carcinoma.

CONCLUSIONS:

We have identified 4 genes (3 uncharacterized and 1 known) that may prove useful in predicting response to interferon-alpha treatment in patients with renal cell carcinoma.

Comment in

PMID:
17382702
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk